SCHEMBL3630248

SCHEMBL3630248

C=C=CC=CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7532225 1.00
SCHEMBL3499331 0.87
SCHEMBL28953103 0.72
SCHEMBL8769435 0.72
SCHEMBL4664048 0.71
SCHEMBL9059321 0.67
SCHEMBL6239077 0.67
SCHEMBL835666 0.67
SCHEMBL835664 0.67
SCHEMBL835665 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940531-B1 FILTRATION MEDIA FOR LIQUID FILTRATION DU PONT (US) 2013-07-17 EP claimed
US-6509426-B2 Dichloro(1,1'-dimethylsilylenebis(2-methyl-4-(4-methoxyphenyl) -4H-azulenyl))zirconium, for example; can produce polyolefin with high molecular weight and high melting point for extrusion or injection moldability JAPAN POLYCHEM CORPORATION (JP) 2003-01-21 US claimed
EP-0873306-B1 Process for hydrocyanation of diolefins DU PONT (US) 2002-03-20 EP claimed
US-5380931-A Oxidative cleavage of polyethylenically unsaturated compound to produce carboxylic acid NDSU RESEARCH FOUNDATION (US) 1995-01-10 US claimed
EP-0083949-B1 THERMOPLASTIC PROPYLENE BLOCK COPOLYMER STAMICARBON B.V. (NL) 1987-05-06 EP claimed
US-4499242-A USING CRYSTALLINE POLYPROPYLENE AND HAVING A BICYCLO/2.2.1/HEPTANE-CONTAINING BACKBONE; IMPACT STRENGTH STAMICARBON B.V. (NL) 1985-02-12 US claimed
EP-0083949-A1 Thermoplastic propylene block copolymer STAMICARBON B.V. (NL) 1983-07-20 EP claimed
US-11865094-B2 Treatment and diagnosis of melanoma THE ROCKEFELLER UNIVERSITY (US) 2024-01-09 US disclosed
EP-4218935-A1 LXRBETA AGONIST FOR THE TREATMENT OF CANCER The Rockefeller University (US) 2023-08-02 EP disclosed
CN-116271053-A Treatment and diagnosis of melanoma 洛克菲勒大学 2023-06-23 CN disclosed
EP-3626309-B1 LXRBETA AGONIST FOR THE TREATMENT OF CANCER UNIV ROCKEFELLER (US) 2023-03-08 EP disclosed
CN-110037999-B Treatment and diagnosis of melanoma 洛克菲勒大学(US) 2023-01-13 CN disclosed
CN-115335081-A Targeted plasma protein degradation 诺华股份有限公司 2022-11-11 CN disclosed
EP-0314435-A2 Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition, processes for their preparation and compositions containing them Sankyo Company Limited (JP) 1989-05-03 EP disclosed
US-4778796-A ω-(3-pyridyl)alkenamide derivatives and anti-allergenic pharmaceutical compositions containing same DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1988-10-18 US disclosed
EP-0226346-A1 Bicyclic sulfonamide derivatives SHIONOGI & CO., LTD. (JP) 1987-06-24 EP disclosed
EP-0210782-A2 Pyridine compounds, process for the preparation thereof and pharmaceutical composition containing the same Dainippon Pharmaceutical Co., Ltd. (JP) 1987-02-04 EP disclosed
US-4499242-A USING CRYSTALLINE POLYPROPYLENE AND HAVING A BICYCLO/2.2.1/HEPTANE-CONTAINING BACKBONE; IMPACT STRENGTH STAMICARBON B.V. (NL) 1985-02-12 US disclosed
EP-0083949-A1 Thermoplastic propylene block copolymer STAMICARBON B.V. (NL) 1983-07-20 EP disclosed
EP-0053823-A1 Optically pure bicyclo (2.2.2) oct-5-en-2-ones, process for their preparation and their utilisation Studiengesellschaft Kohle mbH (DE) 1982-06-16 EP disclosed